- Report
- July 2023
- 135 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- December 2022
- 1588 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- February 2024
- 179 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- April 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Colorectal Cancer Drug market is composed of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is the most common treatment for colon cancer, and is used to kill cancer cells. Targeted therapy is used to target specific molecules in cancer cells, while immunotherapy is used to boost the body’s immune system to fight cancer. Hormone therapy is used to reduce the production of hormones that can cause cancer cells to grow.
Companies in the Colorectal Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, and Roche. Show Less Read more